GSK sets up network to help its suppliers cut emissions

GlaxoSmithKline ($GSK) is working to reduce the environmental impact of its supply chain with an information exchange that allows its suppliers to share ideas on how to improve energy efficiency and reduce environmental impacts. According to, GSK says that 40% of its carbon footprint comes from buying supplies. It is asking 500 suppliers to joint the network and hopes that will result in reducing emissions from its processes by 25%. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.